For the twelve months ended Jun 30, 2026, Anterix Inc. reported $7.04M of revenue and $65.69M of net income.
ATEX revenue was $1.96M in fiscal Q1 2027 (ended Jun 30, 2026), up 38.1% from a year earlier and up 0.0% from the prior quarter. For the full fiscal 2026 it was $6.50M, up 7.8% from fiscal 2025. Compound annual growth was +47.8% over 5 years and +6.3% over 10 years. It rose in 8 of the last 10 fiscal years. Fiscal 2026 is the highest of the 14 fiscal years on file.
ATEX net income was $240.0K in fiscal Q1 2027 (ended Jun 30, 2026), down 99.0% from a year earlier and down 98.7% from the prior quarter. For the full fiscal 2026 it was $90.64M, compared with -$11.37M in fiscal 2025. Fiscal 2026 is the highest of the 14 fiscal years on file.
ATEX diluted EPS was $0.01 in fiscal Q1 2027 (ended Jun 30, 2026), down 99.3% from a year earlier and down 99.0% from the prior quarter. For the full fiscal 2026 it was $4.83, compared with -$0.61 in fiscal 2025.
ATEX free cash flow was $2.01M in fiscal Q1 2027 (ended Jun 30, 2026), compared with -$3.14M a year earlier and down 87.0% from the prior quarter. For the full fiscal 2026 it was $5.48M, compared with -$29.35M in fiscal 2025.
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.50M | $6.03M | $4.19M | $1.92M | $1.08M | $921.0K | $1.56M | $6.50M | $6.36M | $4.79M |
| Cost of revenue | - | - | - | $0 | $5.0K | $1.61M | $2.83M | $4.65M | $7.90M | $7.05M |
| Gross profit | - | - | - | $1.92M | $1.08M | -$685.0K | -$1.27M | -$752.0K | -$1.54M | -$2.26M |
| Research and development | $4.70M | $5.74M | $5.70M | $4.44M | $3.59M | $4.34M | $2.95M | $2.29M | $2.35M | $2.32M |
| Selling, general and admin | $36.06M | $42.67M | $44.42M | $45.18M | $39.52M | $39.30M | $25.47M | $19.62M | $20.86M | $22.55M |
| Operating income | $93.93M | -$11.71M | -$10.12M | -$16.46M | -$36.85M | -$54.81M | -$37.53M | -$42.74M | -$31.73M | -$32.78M |
| Interest expense | - | - | - | - | - | - | - | - | $3.0K | $5.0K |
| Pre-tax income | $95.71M | -$9.48M | -$7.51M | -$15.05M | -$36.54M | -$54.31M | -$35.24M | -$41.30M | -$31.07M | -$32.69M |
| Income tax | $5.07M | $1.89M | $1.61M | $1.26M | $983.0K | $124.0K | $2.40M | $688.0K | -$6.50M | $6.50M |
| Net income | $90.64M | -$11.37M | -$9.13M | -$16.32M | -$37.52M | -$54.43M | -$37.64M | -$41.99M | -$24.57M | -$39.19M |
| EPS, basic | $4.85 | -$0.61 | -$0.49 | -$0.87 | -$2.07 | -$3.13 | -$2.29 | -$2.88 | -$1.70 | -$2.72 |
| EPS, diluted | $4.83 | -$0.61 | -$0.49 | -$0.87 | -$2.07 | -$3.13 | -$2.29 | -$2.88 | -$1.70 | -$2.72 |
| Diluted shares | 18.8M | 18.6M | 18.8M | 18.8M | 18.1M | 17.4M | 16.4M | 14.6M | 14.5M | 14.4M |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $98.53M | $47.37M | $68.12M | $43.18M | $105.62M | $117.54M | $137.45M | $76.72M | $98.32M | $124.08M |
| Receivables | - | - | - | - | $0 | $4.0K | $61.0K | $444.0K | $935.0K | $636.0K |
| Inventory | - | - | - | - | - | - | - | - | $173.0K | $128.0K |
| Current assets | $119.98M | $60.76M | $73.01M | $59.46M | $115.77M | $121.05M | $142.15M | $78.35M | $100.28M | $125.72M |
| Total assets | $465.21M | $333.10M | $324.89M | $278.56M | $278.04M | $253.06M | $267.40M | $196.75M | $220.34M | $245.49M |
| Current liabilities | $35.99M | $27.20M | $17.95M | $31.90M | $9.64M | $8.62M | $8.82M | $8.84M | $5.23M | $4.72M |
| Total liabilities | $202.89M | $176.50M | $163.86M | $98.77M | $91.75M | $40.55M | $22.33M | $15.99M | $11.81M | $17.59M |
| Shareholders' equity | $262.32M | $156.60M | $161.03M | $179.79M | $186.30M | $212.51M | $245.07M | $180.76M | $209.30M | $227.90M |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $5.51M | -$29.26M | $41.99M | -$27.25M | $17.91M | -$9.96M | -$27.82M | -$23.09M | -$21.99M | -$26.50M |
| Capital expenditures | $31.0K | $87.0K | $307.0K | $2.13M | $1.05M | $230.0K | $464.0K | $724.0K | $950.0K | $1.64M |
| Free cash flow | $5.48M | -$29.35M | $41.69M | -$29.38M | $16.86M | -$10.19M | -$28.29M | -$23.81M | -$22.94M | -$28.14M |
| Investing cash flow | $40.53M | $22.75M | $8.09M | -$27.13M | -$27.41M | -$14.17M | -$7.56M | -$1.67M | -$2.88M | -$2.39M |
| Financing cash flow | $3.59M | -$6.59M | -$25.14M | -$8.06M | -$2.42M | $4.22M | $96.11M | $3.16M | -$898.0K | -$485.0K |
| Share repurchases | $990.0K | $8.40M | $24.68M | $8.22M | $14.96M | $0 | $0 | - | - | - |
| Depreciation and amortization | $464.0K | $548.0K | $844.0K | $1.42M | $1.45M | $3.53M | $3.59M | $2.85M | $2.85M | $2.23M |
| Line item | Mar 31, 2026 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | Mar 31, 2019 | Mar 31, 2018 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 7.8% | 43.9% | 118.4% | 77.0% | 17.7% | -41.1% | -75.9% | 2.3% | 32.8% | 35.1% |
| Gross margin | - | - | - | 100.0% | 99.5% | -74.4% | -81.1% | -11.6% | -24.3% | -47.3% |
| Operating margin | 1444.9% | -194.2% | -241.5% | -857.8% | -3399.3% | -5951.0% | -2399.8% | -657.6% | -499.2% | -684.8% |
| Net margin | 1394.2% | -188.6% | -217.8% | -850.3% | -3461.2% | -5910.3% | -2406.5% | -646.1% | -386.6% | -818.6% |
| Free cash flow margin | 84.3% | -486.7% | 994.7% | -1530.8% | 1555.4% | -1106.3% | -1808.6% | -366.4% | -360.9% | -587.9% |
| Return on equity | 34.6% | -7.3% | -5.7% | -9.1% | -20.1% | -25.6% | -15.4% | -23.2% | -11.7% | -17.2% |
| Return on assets | 19.5% | -3.4% | -2.8% | -5.9% | -13.5% | -21.5% | -14.1% | -21.3% | -11.2% | -16.0% |
| Current ratio | 3.33 | 2.23 | 4.07 | 1.86 | 12.01 | 14.05 | 16.11 | 8.86 | 19.18 | 26.63 |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.96M | $1.96M | $1.57M | $1.55M | $1.42M | $1.39M | $1.57M | $1.55M | $1.52M | $1.26M | $1.27M | $1.05M |
| Research and development | $1.22M | $1.27M | $1.10M | $1.21M | $1.12M | $1.09M | $1.12M | $1.78M | $1.75M | $2.24M | $1.24M | $1.15M |
| Selling, general and admin | $9.62M | $8.56M | $8.66M | $8.40M | $10.45M | $9.22M | $9.20M | $11.40M | $12.85M | $9.59M | $11.25M | $11.90M |
| Operating income | -$246.0K | $19.84M | -$9.06M | $60.67M | $22.48M | $9.40M | $7.03M | -$13.13M | -$15.01M | -$10.51M | $969.0K | $2.26M |
| Pre-tax income | $614.0K | $20.38M | -$8.65M | $61.05M | $22.92M | $9.88M | $7.48M | -$12.54M | -$14.30M | -$9.54M | $1.67M | $2.72M |
| Income tax | $374.0K | $1.86M | -$2.05M | $7.52M | -$2.26M | $674.0K | -$234.0K | $230.0K | $1.22M | -$130.0K | $1.34M | $645.0K |
| Net income | $240.0K | $18.52M | -$6.60M | $53.54M | $25.18M | $9.21M | $7.71M | -$12.77M | -$15.52M | -$9.41M | $328.0K | $2.07M |
| EPS, basic | $0.01 | $0.99 | -$0.35 | $2.86 | $1.35 | $0.51 | $0.41 | -$0.69 | -$0.84 | -$0.51 | $0.02 | $0.11 |
| EPS, diluted | $0.01 | $0.97 | -$0.35 | $2.86 | $1.35 | $0.51 | $0.41 | -$0.69 | -$0.84 | -$0.51 | $0.02 | $0.11 |
| Diluted shares | 19.6M | - | 18.7M | 18.7M | 18.7M | - | 18.8M | 18.6M | 18.5M | - | 18.9M | 19.1M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $116.01M | $98.53M | $29.53M | $39.07M | $41.43M | $47.37M | $28.80M | $43.13M | $51.72M | $68.12M | $62.03M | $48.53M |
| Current assets | $153.08M | $119.98M | $50.06M | $58.80M | $55.36M | $60.76M | $40.28M | $56.77M | $65.69M | $73.01M | $77.85M | $62.11M |
| Total assets | $497.93M | $465.21M | $417.00M | $420.38M | $359.58M | $333.10M | $326.68M | $317.24M | $321.14M | $324.89M | $320.88M | $279.88M |
| Current liabilities | $31.55M | $35.99M | $36.02M | $34.62M | $35.95M | $27.20M | $24.40M | $15.81M | $16.52M | $17.95M | $17.26M | $15.30M |
| Total liabilities | $212.13M | $202.89M | $181.05M | $180.03M | $174.81M | $176.50M | $181.93M | $178.17M | $172.35M | $163.86M | $148.62M | $103.78M |
| Shareholders' equity | $285.79M | $262.32M | $235.95M | $240.35M | $184.77M | $156.60M | $144.75M | $139.06M | $148.78M | $161.03M | $172.26M | $176.10M |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.04M | $15.52M | -$8.27M | $1.40M | -$3.14M | -$16.55M | -$7.70M | -$2.65M | -$2.36M | $6.14M | $33.64M | $10.42M |
| Capital expenditures | $36.0K | $22.0K | $9.0K | $0 | $0 | $46.0K | $0 | $41.0K | $0 | $40.0K | $55.0K | $187.0K |
| Free cash flow | $2.01M | $15.50M | -$8.28M | $1.40M | -$3.14M | -$16.60M | -$7.70M | -$2.69M | -$2.36M | $6.10M | $33.59M | $10.23M |
| Investing cash flow | -$6.74M | $46.10M | -$2.30M | -$604.0K | -$2.67M | $35.41M | -$1.72M | -$5.54M | -$5.40M | -$2.26M | -$4.54M | $20.08M |
| Financing cash flow | $19.95M | $5.15M | -$10.0K | -$907.0K | -$642.0K | -$264.0K | -$4.89M | -$362.0K | -$1.07M | -$5.30M | -$8.09M | -$11.01M |
| Share repurchases | - | $0 | $0 | $990.0K | $0 | $1.96M | $4.42M | $0 | $2.03M | $5.97M | $7.97M | $10.73M |
| Depreciation and amortization | $101.0K | $103.0K | $104.0K | $133.0K | $124.0K | $76.0K | $142.0K | $151.0K | $179.0K | $191.0K | $198.0K | $209.0K |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 38.1% | 41.0% | 0.4% | 0.1% | -7.0% | 10.2% | 23.2% | 47.4% | 150.8% | 107.2% | 119.9% | 164.3% |
| Net income growth, YoY | -99.0% | 101.1% | - | - | - | - | 2250.6% | - | - | - | - | - |
| EPS growth, YoY | -99.3% | 90.2% | - | - | - | - | 1950.0% | - | - | - | - | - |
| Operating margin | -12.6% | 1013.0% | -576.0% | 3909.5% | 1585.4% | 676.5% | 449.0% | -846.6% | -984.4% | -834.2% | 76.2% | 214.7% |
| Net margin | 12.3% | 945.9% | -419.6% | 3449.5% | 1775.7% | 662.9% | 492.3% | -823.1% | -1018.0% | -746.9% | 25.8% | 197.1% |
| Free cash flow margin | 102.6% | 791.5% | -526.4% | 90.5% | -221.4% | -1195.2% | -491.6% | -173.4% | -154.8% | 484.1% | 2642.4% | 972.9% |
| Current ratio | 4.85 | 3.33 | 1.39 | 1.70 | 1.54 | 2.23 | 1.65 | 3.59 | 3.98 | 4.07 | 4.51 | 4.06 |
Source: XBRL data Anterix Inc. files with the SEC, latest filing dated Aug 11, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| ATEX | $7.04M | +18.9% | $65.69M | 933.0% | $1.58B |
| VZ | $139.39B | +1.4% | $16.42B | 11.8% | $190.90B |
| TMUS | $93.82B | +9.3% | $11.30B | 12.0% | $178.71B |
| T | $128.85B | +3.5% | $13.13B | 10.2% | $146.82B |
| GLW | $17.72B | +18.8% | $2.24B | 12.6% | $99.88B |
| AMX | MXN 943.64B | +8.6% | MXN 82.82B | 8.8% | $78.39B |
| LITE | $3.74B | +103.2% | -$6.58B | -175.8% | $54.07B |
| CIEN | $6.02B | +32.6% | $654.41M | 10.9% | $38.19B |
| CHT | NT$236.11B | +2.7% | NT$38.70B | 16.4% | $37.90B |